Cargando…

Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs

Human Cytomegalovirus (CMV) can lead to primary infection or reactivation in CMV-seronegative or -seropositive kidney transplant recipients, respectively. Complications comprise severe end-organ diseases and acute or chronic transplant rejection. Risk for CMV manifestation is stratified according to...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlott, Fabian, Steubl, Dominik, Hoffmann, Dieter, Matevossian, Edouard, Lutz, Jens, Heemann, Uwe, Hösel, Volker, Busch, Dirk H., Renders, Lutz, Neuenhahn, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271354/
https://www.ncbi.nlm.nih.gov/pubmed/28129395
http://dx.doi.org/10.1371/journal.pone.0171035
_version_ 1782501335452614656
author Schlott, Fabian
Steubl, Dominik
Hoffmann, Dieter
Matevossian, Edouard
Lutz, Jens
Heemann, Uwe
Hösel, Volker
Busch, Dirk H.
Renders, Lutz
Neuenhahn, Michael
author_facet Schlott, Fabian
Steubl, Dominik
Hoffmann, Dieter
Matevossian, Edouard
Lutz, Jens
Heemann, Uwe
Hösel, Volker
Busch, Dirk H.
Renders, Lutz
Neuenhahn, Michael
author_sort Schlott, Fabian
collection PubMed
description Human Cytomegalovirus (CMV) can lead to primary infection or reactivation in CMV-seronegative or -seropositive kidney transplant recipients, respectively. Complications comprise severe end-organ diseases and acute or chronic transplant rejection. Risk for CMV manifestation is stratified according to the CMV-IgG-serostatus, with donor+/recipient- (D+/R-) patients carrying the highest risk for CMV-replication. However, risk factors predisposing for primary infection in CMV-seronegative recipients are still not fully elucidated. Therefore, we monitored D+/R- high-risk patients undergoing kidney transplantation in combination with antiviral prophylaxis for the incidence of CMV-viremia for a median follow-up time of 784 days (156–1155 days). In this period, we analyzed the functional CMV-specific T cell response by intracellular cytokine staining and CMV-serology by ELISA. Only four of eight D+/R- patients developed clinically relevant CMV-viremia followed by seroconversion. Viremia triggered expansion of functional CMV-specific T cells correlating with protection against secondary CMV-reactivations. In contrast, all other patients remained permanently aviremic and showed no immunological correlate of infection after discontinuation of antiviral prophylaxis for up to three years. Comparing cold ischemic times (CIT) of viremic (median = 1020 min; 720–1080 min) and aviremic patients (median = 335 min; 120–660 min) revealed significantly (p = 0.0286) protracted CIT in patients with primary CMV-infection. Taken together, primary CMV-infection affects only a subgroup of D+/R- patients correlating with length of CIT. Therefore, patients with extended CIT should be thoroughly monitored for CMV-replication well beyond discontinuation of antiviral prophylaxis. In contrast, patients with short CIT remained permanently uninfected and might benefit from shorter prophylactic treatment.
format Online
Article
Text
id pubmed-5271354
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-52713542017-02-06 Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs Schlott, Fabian Steubl, Dominik Hoffmann, Dieter Matevossian, Edouard Lutz, Jens Heemann, Uwe Hösel, Volker Busch, Dirk H. Renders, Lutz Neuenhahn, Michael PLoS One Research Article Human Cytomegalovirus (CMV) can lead to primary infection or reactivation in CMV-seronegative or -seropositive kidney transplant recipients, respectively. Complications comprise severe end-organ diseases and acute or chronic transplant rejection. Risk for CMV manifestation is stratified according to the CMV-IgG-serostatus, with donor+/recipient- (D+/R-) patients carrying the highest risk for CMV-replication. However, risk factors predisposing for primary infection in CMV-seronegative recipients are still not fully elucidated. Therefore, we monitored D+/R- high-risk patients undergoing kidney transplantation in combination with antiviral prophylaxis for the incidence of CMV-viremia for a median follow-up time of 784 days (156–1155 days). In this period, we analyzed the functional CMV-specific T cell response by intracellular cytokine staining and CMV-serology by ELISA. Only four of eight D+/R- patients developed clinically relevant CMV-viremia followed by seroconversion. Viremia triggered expansion of functional CMV-specific T cells correlating with protection against secondary CMV-reactivations. In contrast, all other patients remained permanently aviremic and showed no immunological correlate of infection after discontinuation of antiviral prophylaxis for up to three years. Comparing cold ischemic times (CIT) of viremic (median = 1020 min; 720–1080 min) and aviremic patients (median = 335 min; 120–660 min) revealed significantly (p = 0.0286) protracted CIT in patients with primary CMV-infection. Taken together, primary CMV-infection affects only a subgroup of D+/R- patients correlating with length of CIT. Therefore, patients with extended CIT should be thoroughly monitored for CMV-replication well beyond discontinuation of antiviral prophylaxis. In contrast, patients with short CIT remained permanently uninfected and might benefit from shorter prophylactic treatment. Public Library of Science 2017-01-27 /pmc/articles/PMC5271354/ /pubmed/28129395 http://dx.doi.org/10.1371/journal.pone.0171035 Text en © 2017 Schlott et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Schlott, Fabian
Steubl, Dominik
Hoffmann, Dieter
Matevossian, Edouard
Lutz, Jens
Heemann, Uwe
Hösel, Volker
Busch, Dirk H.
Renders, Lutz
Neuenhahn, Michael
Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs
title Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs
title_full Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs
title_fullStr Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs
title_full_unstemmed Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs
title_short Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs
title_sort primary cytomegalovirus infection in seronegative kidney transplant patients is associated with protracted cold ischemic time of seropositive donor organs
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271354/
https://www.ncbi.nlm.nih.gov/pubmed/28129395
http://dx.doi.org/10.1371/journal.pone.0171035
work_keys_str_mv AT schlottfabian primarycytomegalovirusinfectioninseronegativekidneytransplantpatientsisassociatedwithprotractedcoldischemictimeofseropositivedonororgans
AT steubldominik primarycytomegalovirusinfectioninseronegativekidneytransplantpatientsisassociatedwithprotractedcoldischemictimeofseropositivedonororgans
AT hoffmanndieter primarycytomegalovirusinfectioninseronegativekidneytransplantpatientsisassociatedwithprotractedcoldischemictimeofseropositivedonororgans
AT matevossianedouard primarycytomegalovirusinfectioninseronegativekidneytransplantpatientsisassociatedwithprotractedcoldischemictimeofseropositivedonororgans
AT lutzjens primarycytomegalovirusinfectioninseronegativekidneytransplantpatientsisassociatedwithprotractedcoldischemictimeofseropositivedonororgans
AT heemannuwe primarycytomegalovirusinfectioninseronegativekidneytransplantpatientsisassociatedwithprotractedcoldischemictimeofseropositivedonororgans
AT hoselvolker primarycytomegalovirusinfectioninseronegativekidneytransplantpatientsisassociatedwithprotractedcoldischemictimeofseropositivedonororgans
AT buschdirkh primarycytomegalovirusinfectioninseronegativekidneytransplantpatientsisassociatedwithprotractedcoldischemictimeofseropositivedonororgans
AT renderslutz primarycytomegalovirusinfectioninseronegativekidneytransplantpatientsisassociatedwithprotractedcoldischemictimeofseropositivedonororgans
AT neuenhahnmichael primarycytomegalovirusinfectioninseronegativekidneytransplantpatientsisassociatedwithprotractedcoldischemictimeofseropositivedonororgans